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We have measured bronchial responsiveness (BR) to histamine on two occasions between 5 and 24 h apart, to
determine if conventional and new indices of BR are repeatable. A random sample of 29 healthy male subjects with
a mean age of 19 (SD 3?44) years from a larger study repeated a Yan method test of BR, recording both partial and
maximal expiratory flow–volume (PEFV and MEFV) curves.
From the MEFV curves log-dose slopes (LDS) for forced expiratory volume in 1 sec (FEV1), forced expiratory
flow between 25% and 75% of forced vital capacity (FVC) (FEF25–75%), mean expiratory flow at 30% and 40% of
FVC (MEF30, MEF40), and the first moment of the spirogram (a1) truncated at 75% and 90% of FVC were
calculated, as well as the provocative dose that induces a 20% fall in FEV1 (PD20FEV1). From the PEFV curves
LDS for a175% and a190%, and MEF30 and MEF40 were derived.
Apart from MEF30 and a190% the second test was significantly lower (P50?05) than the first when measuring
the repeatability of spirometric indices, whereas the LDS of the indices showed no significant change. The
repeatability expressed as intra-class correlation coecient (ICC) was highest for LDS FEV1 (0?87), second highest
for LDS MEF40 (0?67) and LDS MEF30 (0?65).
The LDS for moment indices were much less repeatable and the lowest ICC was found in all LDS indices derived
from PEFV curves. Within-subject variance was not influenced by atopic status, smoking habits or recordable
PD20FEV1. As tests for bronchial hyper-responsiveness (BHR) the LDS of FEV1, MEF40 and MEF30 seem to be
acceptable for use in population studies.
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In epidemiological studies of respiratory health a test of
bronchial hyper-responsiveness (BHR) to either histamine
or methacholine is often used as a physiological marker for
effects on bronchii. The commonest measure of BHR is the
provocative dose that induces a 20% fall in forced
expiratory volume in 1 sec (PD20FEV1). However, only
about 10–15% of subjects will have a measurable value for
PD20 and so the majority of subjects have censored data.
An alternative is to calculate a two-point slope of change in
FEV1 against dose, of which the log dose slope (LDS) (1)Received 19 December 2000 and accepted 5 January 2001.
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0954-6111/01/040287+05 $35?00/0has been proposed as a suitable index that is normally
distributed (2), with only few subjects having censored data.
It is possible that more information may be available
from testing BHR by using additional indices. The first
moment of the truncated forced expiratory spirogram
contains information from the whole manoeuvre up to a
given point and is more size-standardized than other indices
(3). Moment analysis is therefore worth considering in the
context of testing BHR. The use of indices from partial
curves, where the bronchodilator effect of a deep inhalation
(DI) is avoided, may also offer additional information
about effects on bronchii (4,5), mainly increased sensitivity
without lower repeatability.
Since the utility of conventional and other indices
of BHR depends on their repeatibility and reproducibility
we have measured conventional tests and other
short-term tests of BHR in a group of normal non-
asthmatic male subjects on two separate occasions and in
addition examined the influence of smoking and atopic
status.# 2001 HARCOURT PUBLISHERS LTD
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MATERIALS
As part of a larger study on 2478 farming students and 967
control subjects in Denmark on the effect of farming on
lung function (6), we invited a random sample of 29 male
healthy subjects to have their bronchial responsiveness
(BR) measured twice within the space of between 5 and
24 h. The study was approved by the Danish Medical Ethics
Committee and all participants gave written consent.
METHODS
BR was measured using the Yan method (7) with calibrated
DeVilbiss No 40 nebulizers (Pennsylvania, U.S.A.) deliver-
ing a cumulative dose of 1?43mg histamine. There were six
provocation doses of histamine with a starting dose of
0?01mg histamine and the last dose given was 0?72mg
histamine. Partial and maximal expiratory flow–volume
(PEFV and MEFV) curves were obtained by a trained
operator with the subjects in a sitting position and nostrils
closed by a clip. The subjects blew into a 200-mm long
plastic upstream assembly which accepts standard 28mm
internal diameter cardboard mouthpieces connected to a
pneumotachograph head (Vitalograph, Buckingham, U.K.)
with a differential capacitance transducer (FC040, Furness
Controls, Bexley, U.K.). The temperature and humidity of
the pneumotachograph was stabilized by use of a fan (8).
Subjects were instructed to hold their head in a neutral
position. The manoeuvre was initiated from a little above
functional residual capacity by a forced expiration to
residual volume, followed immediately by a maximum
inspiration to total lung capacity, followed without hesita-
tion by a forced expiration for as long as possible to
residual volume again. An on-line signal was shown on the
screen through the whole manoeuvre for both the operator
and the subject to help ensure that technically acceptable
blows were recorded. The blows were repeated until
acceptable, aiming to have the start of the partial expiratory
blow below 80% forced vital capacity (FVC) but above
50% FVC. Subjects rested for at least 30 sec between blows.
The following indices were derived from the blows: forced
expiratory volume in 1 sec (FEV1), forced expiratory flow
between 25% and 75% of FVC (FEF25–75%), maximum
expiratory flow at 30% and 40% of the largest FVC
recorded prehistamine (MEF30 and MEF40, respectively),
and the first moment of the spirogram truncated at 75%
and 90% of FVC (4) which are termed a175% and a190%,
respectively. From the partial curves the moments were
derived MEF30 and MEF40. The first moment a1 of the
manoeuvre is derived by considering the volume time
(spirogram) of the manoeuvre as a succession of transit
time. Transit time is the duration of equal volume increments
expired. The data must be timed from a new start time zero
defined by back-extrapolation (9). The moments of the
spirogram are standardized by truncation with respect to
volume (3) and following this previous work truncation at
75% and 90% of expired volume was performed.BHR was measured using the method of PD20 and LDS
(1) following the formula below:
LDS FEV1= log10(((FEV1start7FEV1end)*100/( FEV1
start *final dose))+1).
LDS were calculated as above for all indices from MEFV
curves. LDS were also calculated for indices derived from
the PEFV curves from subjects whose start position for the
partial manoeuvre was below 80% of FVC and above 50%
FVC for MEF40, and above 40% FVC for MEF30.
Data were censored if there was an increase of an index
of more than 5% when ending challenge compared to the
prechallenge value. Indices derived from the PEFV curve
data were also censored if the start position was outside 80–
50%/40% FVC.
All subjects had skin-prick tests performed to 10
common inhalant allergens (Soluprick ALK, ALJ-Abello,
Copenhagen, Denmark) extended with allergens from
storage mites (Tyrophagus putrescentia, Accarus siro and
Lepidiglyphus destructor), moulds, cows, pigs and horses.
Subjects were deemed atopic if they had a wheal response
more than 2mm greater than the control for any one of
these allergens.
STATISTICS
Comparisons between the indices on the two test sessions
were by Wilcoxon sign-rank test, since the differences were
not normally distributed. Differences from the mean for
repeated measures of LDS for indices were also assessed.
Intra-class correlation coecients (ICC) were derived to
express the equivalent of a signal : noise ratio. The ICC is
the ratio of between person variance to the sum of within-
and between-person variances, such that an ICC of 1?0 is
best when the within-subject variance is zero. A level of 5%
was taken as significant.
Results
From the 29 subjects, mean age 19 (SD 3?44) years, there
were seven subjects with a recordable PD20 for FEV1 on the
first testing and six on the second, with five having a PD20
on both occasions.
The results for the lung function indices are shown in
Table 1. There were significant changes in all the indices
between the two tests except for MEF30 and a190%, with
the second test being larger for a175% and smaller for all
other indices. Table 2 shows the mean (SD) of the LDS for
FEV1, FEF25–75%, MEF30, MEF40, a175%, a190%, and
LDS calculated for the absolute change in FEV1 and
a175%. There were no significant changes in any of the
LDS. Intra-class correlation coecients (ICC) showed that
the LDS for FEV1 (0?87) was the best test, with the LDS for
MEF30 (0?65) and MEF40 (0?67) being the next best. The
ICC for a175% was 0?49 and for a190% was 0?48. Figures 1
and 2 show the differences against the means for repeated
measures of the LDS for FEV1 and MEF40, respectively.
When considering the indices from the PEFV curve the
number of subjects with an admissible start of their PEFV
curve was 18 and 12 for MEF40 and MEF30, respectively,
TABLE 1. Mean and standard deviation (SD) of the lung function indices for the 29 subjects on the first test, together with the
mean differences between the two tests. The P-value is from a Wilcoxon sign-rank test on the difference
Mean first SD first Mean differences SD difference P (difference)
FEV1 (l) 4?38 0?70 0?16 0?23 50?01
FVC (l) 5?25 0?79 0?10 0?26 0?02
PEF (l sec71) 9?01 1?85 0?41 0?80 0?02
FEF25–75% (l sec
71) 4?51 1?07 0?25 0?61 0?02
MEF30 (l sec
71) 2?90 0?95 0?16 0?62 0?12
MEF40 (l sec
71) 3?94 1?08 0?26 0?70 0?03
a175% 0?30 0?06 70?02 0?04 0?04
a190% 0?43 0?09 70?02 0?06 0?08
TABLE 2. Mean and SD of the LDS from indices from the MEFV curve for the first reading, the differences between the two
readings, their intra-class correlation coecient (ICC), the mean within-subject variance (w_var) and the number of subjects
with valid data on both occasions (N). The P-value is from a Wilcoxon sign-rank test on the differences
Mean first SD first Mean difference SD difference P difference ICC w_var N
FEV1 (l) 0?93 0?47 70?04 0?19 0?24 0?87 0?02 23
FEF25–75% (l sec
71) 1?09 0?70 70?24 0?64 0?10 0?28 0?22 26
MEF30 (l sec
71) 1?32 0?52 70?04 0?33 0?32 0?65 0?05 23
MEF40 (l sec
71) 1?33 0?45 70?02 0?30 0?32 0?67 0?04 23
a175% 1?20 0?33 70?002 0?32 0?98 0?49 0?07 24
a190% 1?18 0?41 70?09 0?38 0?35 0?48 0?08 25
FIG. 1. Difference against mean for repeated measures for
the LDS of FEV1.
FIG. 2. Difference against mean for repeated measures for
the LDS of MEF40.
THE MEFV CURVE AND SHORT-TERM REPEATABILITY 289and for the moment indices the number was 10 and 11,
respectively. The results for the LDS for these indices are
shown in Table 3. None of these showed a significant
change in value between the two tests, but the ICC for all
were much smaller than for the other indices (0?35–0?05).The within-subject variance in LDS of the indices was
neither significantly different for the eight atopic subjects
compared with the non-atopic, nor for the 11 current
smokers compared with the non-smokers, nor for the five
PD20 FEV1-positive compared to the PD20 FEV1-negative.
TABLE 3. Mean and SD of the LDS from the indices from the PEFV curve for the first reading, the differences between the two
readings, their intra-class correlation coecient (ICC), the mean within-subject variance (w_var) and the number of subjects
with valid data on both occasions (N). The P-value is from a Wilcoxon sign-rank test on the differences
Mean first SD first Mean difference SD difference P difference ICC w_var N
MEF30P 1?50 0?21 70?05 0?29 0?37 0?27 0?04 18
MEF40P 1?41 0?33 70?06 0?49 0?64 0?05 0?11 12
a175%P 1?20 0?43 70?21 0?43 0?18 0?26 0?21 10
a190%P 1?18 0?40 70?18 0?42 0?45 0?35 0?11 11
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We have found that the LDS for FEV1 remains the most
repeatable test of BHR and yet retains sucient between-
subject variation to reflect true subject differences. The LDS
from indices of the PEFV curve do not seem to offer any
advantage. Repeatability for the dose–response slope of
FEV1 was found to be good in Australian children (10) and
in adults with a PD20FEV1 and but was less repeatable in
subjects with no recordable PD20FEV1 (11). Chinn et al.
(12) found an ICC of 0?66 to PD20FEV1 using a least-
squares slope of FEV1. Whilst indices from PEFV curves
yield information about the resting bronchial tone and
whether this can be relieved by a deep inspiration, we have
not found any merit from LDS derived from indices from
the partial curve. Others have found a high sensitivity and
repeatability of indices derived from the partial curve in
respiratory healthy subjects (4) and in subjects with asthma
(5) with an ICC of (0?69) close to the value for PD20FEV1
(0?79) (5). The difference in our findings might be due to
different methods and techniques, study populations and
outcome variables. Both Sterk et al. (4) and Knox et al. (5)
derived the provocation dose that caused a 40% drop in
flow at 40% (4) and 30% (5) of vital capacity measured
from the partial curve, whereas we derived LDS.
Second to the LDS for FEV1 were the LDS for MEF30
and MEF40 that were the next most promising. The
response slope of MEF50 and MEF25 has been found with
a higher sensitivity than FEV1 but their suitability might be
limited due to larger baseline variations (13,14). Although
the moment indices have been found to be highly repeatable
in normal spirometry (3), we found them to be less good as
indices of BHR, with a reasonable between-subject variance
but less repeatable within-subject variance. It was a surprise
that the FEF25–75% was not very good. This is usually a
repeatable test within subjects (15) but the LDS for this
varied widely; some subjects had a negative slope (i.e. a rise
in FEF25–75% after histamine) on one test and positive slope
(i.e. a fall in FEF25–75% after histamine) on the next.
Our results for ICC depend on both the within-subject
variation and the between-subject variation in the group.
Between-subject variance is predetermined by group
composition and if this variance was unduly small it would
minimize the importance of a particular test. Our subjects
were chosen at random from a larger population and
selection was independent of any lung function or othercharacteristic. Among our subjects were five who had a
recordable PD20 for FEV1 on both occasions. We therefore
believed that there were sucient subjects in our group with
a change in FEV1 and their airway function to histamine to
give a reasonable between-subject variance.
We found that our subjects did less well in their
conventional lung function tests on the second testing. This
might have been due to changes in calibration of the
pneumotachograph. However, the moment indices are not
susceptible to changes in calibration as they are volume-
standardized and both these indices were also less good on
the second test. This suggests that the subjects did less well
in their manoeuvres on the second test due to a change in
motivation or other factor between the two series. Any
effect from the histamine should have worn off as the
shortest interval between tests was 5 h and full recovery
from histamine effect has been found to be about 40min
(16). The LDS derived from percentage change would not
be influenced by any change in calibration factor and would
only be changed by within-subject motivation altering
within the test. We did not find any evidence for this, and
there was no significant change in any LDS between tests.
In conclusion, we have found that the short-term
repeatability of BR to histamine was highest for LDS
FEV1, followed by LDS MEF40 and MEF30. These tests
appear satisfactory for use in population studies. The LDS
for the moment indices were much less repeatable, as were
those from the PEFV curves, and these tests are less likely
to offer any useful signal when testing BHR.
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